Results 181 to 190 of about 1,183,948 (211)

Microparticles in Chronic Heart Failure

2017
Heart failure (HF) continues to have a sufficient impact on morbidity, mortality, and disability in developed countries. Growing evidence supports the hypothesis that microparticles (MPs) might contribute to the pathogenesis of the HF development playing a pivotal role in the regulation of the endogenous repair system, thrombosis, coagulation ...
openaire   +2 more sources

The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

New England Journal of Medicine, 1996
Milton Packer
exaly  

Cardiac Resynchronization in Chronic Heart Failure

New England Journal of Medicine, 2002
Milton Packer
exaly  

Chronic heart failure - treatment

DMW - Deutsche Medizinische Wochenschrift, 2002
M, Kindermann, I, Janzen, B, Hennen, M, Böhm   +3 more
openaire   +2 more sources

Effect of Carvedilol on Survival in Severe Chronic Heart Failure

New England Journal of Medicine, 2001
Milton Packer, Andrew Coats, Michal Tendera   +2 more
exaly  

Digoxin in chronic heart failure

The Lancet, 1995
openaire   +2 more sources

Chronic heart failure - diagnosis

DMW - Deutsche Medizinische Wochenschrift, 2002
M, Kindermann, I, Janzen, B, Hennen, M, Böhm   +3 more
openaire   +2 more sources

Effect of Amlodipine on Morbidity and Mortality in Severe Chronic Heart Failure

New England Journal of Medicine, 1996
Milton Packer, David L Demets
exaly  

Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure

New England Journal of Medicine, 1990
Larry Mayer, Milton Packer
exaly  

Withdrawal of Digoxin from Patients with Chronic Heart Failure Treated with Angiotensin-Converting-Enzyme Inhibitors

New England Journal of Medicine, 1993
Milton Packer, Mihai Gheorghiade
exaly